Trial intelligence / Profile preview

Nanocurcumin and chlorhexidine mouthwash effect on prostaglandin E2 during teeth shifting

IRCT20220223054108N2Phase 3Completed

Sponsor
Golestan University of Medical Sciences
Start
Jun 2023
Modality
Small Molecules, Nanoparticles → Drug Delivery Systems
Countries
1
01

Overview

Phase 3 trial of nanocurcumin and chlorhexidine in malocclusion and dental malposition (2 arms), sponsored by Golestan University of Medical Sciences. Started Jun 2023; status: completed.

02

Drugs

nanocurcuminchlorhexidine
03

Conditions

malocclusiondental malposition

Beyond the preview

Go deeper on IRCT20220223054108N2.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20220223054108N2.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call